Developing efficacious vaccines for human malaria caused by Plasmodium falciparum is a
major global health priority, although this has proven to be immensely challenging over the …

Numerous efforts to understand the functional roles of antibodies demonstrated that they can
protect against malaria. However, it is unclear which antibody responses are the best …

Antibody immunity against malaria is effective but non-sterile. In addition to antibody-
mediated inhibition, neutralisation or opsonisation of malaria parasites, antibody-mediated …

The malaria parasite has for long been thought to escape host complement attack as a
survival strategy. However, it was only recently that complement evasion mechanisms of the …

Abstract Background Antibodies targeting Plasmodium falciparum sporozoites play a key
role in human immunity to malaria. However, antibody mechanisms that neutralize …

Malaria remains a significant contributor to the global burden of disease, with around 40% of
the world's population at risk of Plasmodium infections. The development of an effective …

Evidence accumulated through the years clearly indicates that antiparasite immune
responses can efficiently control malaria parasite infection at all development stages, and …

Introduction A vaccine would greatly accelerate current global efforts toward malaria
elimination. While a partially efficacious vaccine has been achieved for Plasmodium …

The past decade has witnessed dramatic decreases in malaria‐associated mortality and
morbidity around the world. This progress has largely been due to intensified malaria control …

Malaria is a global infectious disease that remains a leading cause of morbidity and mortality
in the developing world. Multiple environmental and host and parasite factors govern the …